Home Xiangyu Medical and the First Affiliated Hospital of Nanchang University Sign Strategic Cooperation Agreement to Advance Medical-Engineering Integration

Xiangyu Medical and the First Affiliated Hospital of Nanchang University Sign Strategic Cooperation Agreement to Advance Medical-Engineering Integration

Jun 11, 2026 19:02 CST Updated 19:02
Sunnyou

Intelligent Rehabilitation Equipment R&D and Manufacturer

(Source:Sunnyou Medical

On June 10, 2026, Sunnyou Medical and the First Affiliated Hospital of Nanchang University held a strategic cooperation signing ceremony. Leveraging their respective core strengths, both parties will engage in deep collaboration focusing on frontier fields such as rehabilitation medicine, brain-computer interfaces, and AI-driven healthcare, working together to address clinical pain points and promote the high-quality development of China’s rehabilitation industry.

Liao Lan, Secretary of the Party Committee of the First Affiliated Hospital of Nanchang University; Li Jianming, Member of the Party Committee and Vice President; Huang Xia, Member of the Party Committee and Vice President; Cui Lulu, Deputy Secretary of the Party Committee and Marketing Director of Sunnyou Medical; He Haifeng, Strategic Product Director and Head of Product Planning; Li Yunhua, General Manager of the Central China Region; and other representatives from both sides attended the ceremony. The ceremony was presided over by Vice President Huang Xia.

At the ceremony, Secretary Liao Lan introduced the hospital’s proactive explorations in fields such as brain-computer interfaces and the integration of artificial intelligence with healthcare. She emphasized that the collaboration between the two parties represents a deep integration of clinical medical resources with high-end manufacturing industry platforms, expressing the hope that this partnership will drive the convergence of medicine and engineering to greater depth and substance, yielding cooperative outcomes that are quantifiable, evaluable, and translatable.

Director Cui Lulu stated,The First Affiliated Hospital of Nanchang University, as one of the first batch of Grade A tertiary hospitals in China, has been rated A+ in the national performance assessment of public tertiary hospitals for seven consecutive years,With robust clinical and research capabilities, the two parties share a solid foundation for cooperation and broad prospects.She emphasized that Sunnyou fully supports the implementation of the cooperative projects, looking forward to both parties collaborating in brain-computer interfaces and rehabilitation.RobotAchieve Substantive Breakthroughs in Cutting-Edge Fields, leveraging innovative achievements in the integration of medicine and engineering to support the construction of a Healthy China.

Witnessed by the leaders of both parties, Vice President Li Jianming and Manager Li Yunhua signed the "Strategic Cooperation Framework Agreement" on behalf of their respective organizations. In the future, the two parties will focus on core areas such as innovative applications in rehabilitation medicine, clinical research in brain science and brain-computer interfaces, and the development of intelligent medical equipment. They aim to establish a complete innovation chain—from identifying clinical needs and developing specialized technologies to conducting in-hospital clinical validation and achieving industrialization of outcomes—thereby injecting new momentum into technological innovation in domestic rehabilitation healthcare.

Following the signing, Manager Li Yunhua introduced the scope of cooperation and next steps for both parties. The two sides held in-depth discussions on matters including the implementation of the partnership and project advancement.

Sunnyou Medical will leverage this strategic partnership as an opportunity to deepen its commitment to brain-computer interfaces and AI-powered smart rehabilitation, guided by clinical needs in R&D. By promoting the deep integration and synchronized development of research and clinical practice, Sunnyou aims to empower the implementation of the Healthy China strategy with robust medical-engineering innovations, contributing to the advancement of national public health.